Barrett & Company
WST icon

Barrett & Company’s West Pharmaceutical WST Stock Holding History

Barrett & Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.4K Hold
74
– – 0.01% 368
2026
Q2 		$26.6K Sell
74
-75
-50% -$22.9K 0.01% 385
2026
Q1 		$37.3K Hold
149
– – 0.01% 325
2025
Q4 		$41K Hold
149
– – 0.01% 320
2025
Q3 		$39.1K Hold
149
– – 0.01% 327
2025
Q2 		$32.6K Hold
149
– – 0.01% 353
2025
Q1 		$33.4K Hold
149
– – 0.01% 315
2024
Q4 		$48.8K Sell
149
-25
-14% -$7.87K 0.02% 272
2024
Q3 		$52.2K Sell
174
-115
-40% -$35.2K 0.02% 253
2024
Q2 		$95.3K Hold
289
– – 0.04% 200
2024
Q1 		$114K Hold
289
– – 0.05% 184
2023
Q4 		$102K Hold
289
– – 0.06% 186
2023
Q3 		$109K Hold
289
– – 0.06% 170
2023
Q2 		$111K Hold
289
– – 0.06% 170
2023
Q1 		$100K Hold
289
– – 0.06% 175
2022
Q4 		$68.1K Hold
289
– – 0.05% 208
2022
Q3 		$68.1K Buy
+289
New +$88K 0.05% 208

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Barrett & Company's WST Position: Q3 2026 in Review

Barrett & Company held its West Pharmaceutical (WST) position steady in Q3 2026 at 74 shares worth $27.4K. The position accounts for 0.01% of the portfolio, ranked #368.

Barrett & Company first reported a position in WST in Q3 2022 and has held it in 17 quarters since. The position peaked at $114K in Q1 2024. 430 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Barrett & Company held 74 shares of West Pharmaceutical worth $27.4K as of Q3 2026.
  • Barrett & Company left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up 0.01% of Barrett & Company's portfolio in Q3 2026, its #368 holding.
  • Barrett & Company first reported a position in West Pharmaceutical in Q3 2022 and has held it in 17 quarters since.
  • Barrett & Company's West Pharmaceutical position peaked at $114K in Q1 2024.
  • 430 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.